ketoconazole has been researched along with thromboxane a2 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maier, RV; Williams, JG | 1 |
Alexander, F; Hechtman, HB; Lelcuk, S; Shepro, D; Valeri, CR | 1 |
Hechtman, HB; Krausz, MM; Levine, L; Shepro, D; Utsonomiya, T | 1 |
Hechtman, HB; Huval, WV; Lelcuk, S; Shepro, D; Valeri, CR | 1 |
Bilić, A; Culo, F; Jagić, V; Rados, M; Renić, M; Sabolović, D | 1 |
Kanda, N; Watanabe, S | 1 |
1 trial(s) available for ketoconazole and thromboxane a2
Article | Year |
---|---|
Inhibition of ischemia-induced thromboxane synthesis in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arm; Blood Platelets; Female; Humans; Ischemia; Ketoconazole; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
5 other study(ies) available for ketoconazole and thromboxane a2
Article | Year |
---|---|
Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome).
Topics: Animals; Blood Coagulation Factors; Ketoconazole; Leukotriene B4; Macrophages, Alveolar; Rabbits; Respiratory Distress Syndrome; Thromboxane A2 | 1992 |
Thromboxane A2 moderates permeability after limb ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Permeability; Dogs; Extremities; Ischemia; Ketoconazole; Thromboxane A2; Thromboxane B2 | 1985 |
Thromboxane mediation of cardiopulmonary effects of embolism.
Topics: Animals; Dogs; Epoprostenol; Female; Heart; Imidazoles; Indomethacin; Ketoconazole; Male; Piperazines; Platelet Count; Pulmonary Embolism; Thromboxane A2; Thromboxanes; Time Factors; Vascular Resistance | 1982 |
Ketoconazole inhibits acetaminophen-induced hepatotoxicity in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dinoprostone; Female; Ketoconazole; Leukotriene C4; Liver; Male; Mice; Mice, Inbred CBA; Thromboxane A2 | 1995 |
Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes.
Topics: Antifungal Agents; Cells, Cultured; Chemokine CCL2; Chemokine CCL27; Chemokine CCL5; Chemokines; Chemokines, CC; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression; Humans; Keratinocytes; Ketoconazole; Male; Naphthalenes; NF-kappa B; Oligonucleotides, Antisense; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terbinafine; Thromboxane A2; Tumor Necrosis Factor-alpha | 2006 |